From humans to canines: Unraveling the impact of metabolic health on mammary cancer across species
DOI:
https://doi.org/10.17533/udea.rccp.v38n3a4Keywords:
Biomarkers, breast cancer, canine mammary tumor, comparative oncology, diet and lifestyle, insulin resistance, metabolic health, obesityAbstract
Background: The relationship between metabolic health and breast cancer has emerged as an expanding area of research in comparative oncology, particularly highlighted in studies conducted among humans and canines. Objective: This review explores how dietary habits, obesity, and metabolic syndromes influence the risk, progression, and response to breast cancer treatments. Methods: To this end, the impact of obesity, diet, and lifestyle on carcinogenesis mechanisms and prognosis in human and canine patients affected by mammary tumors was examined. Results: By examining comparative studies addressing the relationship between metabolic health and breast cancer in women and canines, common molecular and biochemical pathways in both species were identified. Conclusions: This approach provides a broader understanding of oncological diseases and their development, suggesting potential strategies for the prevention, diagnosis, and treatment of breast cancer from a metabolic perspective. However, as this area of research is still developing, it is necessary to explore new research lines to fully understand the complex relationship between metabolic health and cancer across different species from biochemical, molecular, genetic, and epigenetic perspectives. The goal is to gain valuable knowledge that contributes to the development of new diagnostic, prognostic, and therapeutic tools.
Downloads
References
Abdelmegeed SM, Mohammed S. Canine mammary tumors as a model for human disease. Oncol Lett 2018; 15(6): 8195-8205. https://doi.org/10.3892/ol.2018.8411
Ahmed SBM, Radwan N, Amer S, Saheb SharifAskari N, Mahdami A, Samara KA, Halwani R, Jelinek HF. Assessing the link between diabetic metabolic dysregulation and breast cancer progression. Int J Mol Sci. 2023; 24(14): 11816. https://doi.org/10.3390/ijms241411816
Andò S, Naimo GD, Gelsomino L, Catalano S, Mauro L. Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression. Obes Rev. 2020; 21(5): e13004. https://doi.org/10.1111/obr.13004
Balaban S, Shearer RF, Lee LS, van Geldermalsen M, Schreuder M, Shtein HC, Cairns R, Thomas KC, Fazakerley DJ, Grewal T, Holst J, Saunders DN, Hoy AJ. Adipocyte lipolysis links obesity to breast cancer growth: adipocytederived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab. 2017; 5(1). https://doi.org/10.1186/s40170-016-0163-7
Bhardwaj P, Brown KA. Obese Adipose Tissue as a Driver of Breast Cancer Growth and Development: Update and Emerging Evidence. Front Oncol. 2021; 11: 638918 https://doi.org/10.3389/fonc.2021.638918
Brantley KD, Zeleznik OA, Dickerman BA, Balasubramanian R, Clish CB, Avila-Pacheco J, Rosner B, Tamimi RM, Eliassen AH. A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses' Health Studies. Br J Cancer. 2022; 127: 1076-1085. https://doi.org/10.1038/s41416-022-01873-9
Bergholtz H, Lien T, Lingaas F, Sørlie T. Comparative analysis of the molecular subtype landscape in canine and human mammary gland
tumors. J Mammary Gland Biol Neoplasia 2022; 27: 171-183. https://doi.org/10.1007/s10911-022-09523-9
Chu DT, Phuong TNT, Tien NLB, Tran DK, Nguyen TT, Thanh VV, Quang TL, Minh LB, Pham VH, Ngoc VTN, Kushekhar K, Chu-Dinh T. The effects of adipocytes on the regulation of breast cancer in the tumor microenvironment: An update. Cells 2019; 8(8): 857. https://doi.org/10.3390/cells8080857
Chung H, Lee S, Kim GA, Kim WH. Downexpression of klotho in canine mammary gland tumors and its prognostic significance. PLoS One 2022; 17(6): e0265248. https://doi.org/10.1371/journal.pone.0265248
De Santi M, Annibalini G, Marano G, Biganzoli G, Venturelli E, Pellegrini M, Lucertini F, Brandi G, Biganzoli E, Barbieri E, Villarini A. Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study. J Cancer Res Clin Oncol. 2023; 149: 8639-8648. https://doi.org/10.1007/s00432-023-04755-6
Durrani IA, Bhatti A, John P. The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxiahyperglycemia axis. Cancer Cell Int. 2021; 21: 351. https://doi.org/10.1186/s12935-021-02040-5
Feigelson HS, Bodelon C, Powers JD, Curtis RE, Buist DSM, Veiga LHS, Aiello Bowles EJ, Berrington de Gonzalez A, Gierach GL. Body
Mass Index and Risk of Second Cancer Among Women With Breast Cancer. JNCI: J Natl Cancer Inst. 2021; 113(9): 1156–1160. https://doi.org/10.1093/jnci/djab053
Gherman LM, Tomuleasa D, Cismaru A, Nutu A, Berindan-Neagoe I. Exploring the contrasts: in-depth analysis of human and
canine mammary tumors - discoveries at the frontier. Med Pharm Rep. 2024; 97(2): 132–142. https://doi.org/10.15386/mpr-2733
Gray M, Turnbull AK, Meehan J, Martínez Pérez C, Kay C, Pang LY, Argyle DJ. Comparative analysis of the development of acquired
radioresistance in canine and human mammary cancer cell lines. Front Vet Sci. 2020; 7: 439. https://doi.org/10.3389/fvets.2020.00439
Guinan EM, Connolly EM, Kennedy MJ, Hussey J. The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a crosssectional study. Nutr J. 2013; 12(99). https://doi.org/10.1186/1475-2891-12-99
Haseen SD, Khanam A, Sultan N, Idrees F, Akhtar N, Imtiaz F. Elevated fasting blood glucose is associated with increased risk of breast
cancer: outcome of case-control study conducted in Karachi, Pakistan. Asian Pac J Cancer Prev. 2015; 16(2): 675-678. https://doi.org/10.7314/APJCP.2015.16.2.675
Irac SE, Oksa A, Jackson K, Herndon A, Allavena R, Palmieri C. Cytokine expression in canine lymphoma, osteosarcoma, mammary gland tumor, and melanoma: Comparative aspects. Vet Sci. 2019; 6(2): 37. https://doi.org/10.3390/vetsci6020037
Inglebert M, Dettwiler M, Hahn K, Letko A, Drogemuller C, Doench J, Brown A, Memari Y, Davies HR, Degasperi A, Nik-Zainal S, Rottenberg S. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Sci Rep. 2022; 12: 18051. https://doi.org/10.1038/s41598-022-21706-2
Kwon JY, Moskwa N, Kang W, Fan TM, Lee C. Canine as a Comparative and Translational Model for Human Mammary Tumor. J Breast
Cancer. 2023; 26(1): 1–13. https://doi.org/10.4048/jbc.2023.26.e4
Leftin A, Ben-Chetrit N, Joyce JA, Koutcher JA. Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy. Sci Rep. 2019; 9: 857. https://doi.org/10.1038/s41598-018-37408-7
Lim HY, Im KS, Kim NH, Kim HW, Shin JI, Sur JH. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary
tumors. Vet J. 2015a; 203(3): 326–331. https://doi.org/10.1016/j.tvjl.2015.01.005
Lim HY, Im KS, Kim NH, Kim HW, Shin JI, Yhee JY, Sur JH. Effects of Obesity and ObesityRelated Molecules on Canine Mammary Gland
Tumors. Vet Pathol. 2015b; 52(6): 1045–1051. https://doi.org/10.1177/0300985815579994
Lim HY, Seung BJ, Cho SH, Kim SH, Bae MK, Sur JH. Canine mammary cancer in overweight or obese female dogs is associated with intratumoral microvessel density and macrophage counts. Vet Pathol. 2022; 59(1): 39–45. https://doi.org/10.1177/03009858211040481
Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N. Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003-2006). Cancer Causes Control. 2010; 21(2): 283–288. https://doi.org/10.1007/s10552-009-9460-6
Mahboobifard F, Pourgholami MH, Jorjani M, Dargahi L, Amiri M, Sadeghi S, Tehrani FR. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed Pharmacother. 2022; 156: 113808. https://doi.org/10.1016/j.biopha.2022.113808
Mao C, Wang M, Li L, Tang JH. Circulating metabolites serve as diagnostic biomarkers for HER2-positive breast cancer and have predictive value for trastuzumab therapy outcomes. J Clin Lab Anal. 2022; 36(2): e24212. https://doi.org/10.1002/jcla.24212
Marchi PH, Vendramini THA, Perini MP, Zafalon RVA, Amaral AR, Ochamotto VA, Da Silveira JC, Dagli MLZ, Brunetto MA. Obesity, inflammation, and cancer in dogs: Review and perspectives. Front Vet Sci. 2022; 9: 1004122. https://doi.org/10.3389/fvets.2022.1004122
Melvin JC, Garmo H, Holmberg L, Hammar N, Walldius G, Jungner I, Lambe M, Van Hemelrijck M. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort. BMC Cancer 2017; 17(246). https://doi.org/10.1186/s12885-017-3232-6
Moestue SA, Dam CG, Gorad SS, Kristian A, Bofin A, Mælandsmo GM, Engebråten O, Gribbestad IS, Bjørkøy G. Metabolic biomarkers
for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res. 2013; 15: R16. https://doi.org/10.1186/bcr3391
Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, Ziegler RG. A Metabolomics Analysis of Body Mass Index
and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst. 2018; 110(6): 588–597. https://doi.org/10.1093/jnci/djx244
Motoki AH, Buttros DAB, Gaspar AL, AlmeidaFilho BS, Carvalho-Pessoa E, Vespoli HDL, NahasNeto J, Nahas EAP. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women. Clin Breast Cancer. 2022; 22(2): e253–e261. https://doi.org/10.1016/j.clbc.2021.07.009
Naaman SC, Shen S, Zeytinoglu M, Iyengar NM. Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation. J Clin Endocrinol Metab. 2022; 107(8): 2154–2166. https://doi.org/10.1210/clinem/dgac241
Nehme R, Diab-Assaf M, Decombat C, Delort L, Caldefie-Chezet F. Targeting adiponectin in breast cancer. Biomedicines 2022; 10(11): 2958. https://doi.org/10.3390/biomedicines10112958
Nicchio BO, Barrouin-Melo SM, Machado MC, Vieira-Filho CH, Santos FL, Martins-Filho EF, Barbosa VF, Barral TD, Portela RW, Damasceno
KA, Estrela-Lima A. Hyperresistinemia in Obese Female Dogs With Mammary Carcinoma in Benign-Mixed Tumors and Its Correlation
With Tumor Aggressiveness and Survival. Front Vet Sci. 2020; 7: 509. https://doi.org/10.3389/fvets.2020.00509
Nguyen HL, Geukens T, Maetens M, Aparicio S, Bassez A, Borg A, Brock J, Broeks A, Caldas C, Cardoso F, De Schepper M, Delorenzi M,
Drukker CA, Glas AM, Green AR, Isnaldi E, Eyfjörð J, Khout H, Knappskog S, Krishnamurthy S, Lakhani SR, Langerod A, Martens JWM, Reed MAE, Murphy L, Naulaerts S, Nik-Zainal S, Nevelsteen I, Neven P, Piccart M, Poncet C, Punie K, Purdie C, Rakha EA, Richardson A, Rutgers E, Vincent-Salomon A, Simpson PT, Schmidt MK, Sotiriou Christos, Span PN, Tan KTB, Thompson A, Tommasi S, Van Baelen KV, Van de Vijver M, Van Laere S, van’t Veer L, Viale G, Viari A, Vos H, Witteveen AT, Wildiers H, Floris G, Garg AD, Smeets A, Lambrechts D, Biganzoli E, Richard F, Desmedt C. Obesity-associated changes in molecular biology of primary breast cancer. Nat Commun. 2023; 14: 4418. https://doi.org/10.1038/s41467-023-39996-z
Nguyen F, Peña L, Ibisch C, Loussouarn D, Gama A, Rieder N, Belousov A, Campone M, Abadie J. Canine invasive mammary carcinomas
as models of human breast cancer. Part 1: natural history and prognostic factors. Breast Cancer Res Treat. 2018; 167: 635–648. https://doi.org/10.1007/s10549-017-4548-2
Oh JH, Cho JY. Comparative oncology: overcoming human cancer through companion animal studies. Exp Mol Med. 2023; 55: 725–734. https://doi.org/10.1038/s12276-023-00977-3
Park B, Kim S, Kim H, Cha C, Chung MS. Associations between obesity, metabolic health, and the risk of breast cancer in East Asian
women. Br J Cancer. 2021; 125: 1718–1725. https://doi.org/10.1038/s41416-021-01540-5
Park YM, White AJ, Nichols HB, O'Brien KM, Weinberg CR, Sandler DP. The association between metabolic health, obesity phenotype
and the risk of breast cancer. Int J Cancer. 2017; 140(12): 2657–2666. https://doi.org/10.1002/ijc.30684
Patrício M, Pereira J, Crisóstomo J, Matafome P, Gomes M, Seiça R, Caramelo F. Using Resistin, glucose, age and BMI to predict the presence of breast cancer. BMC Cancer 2018; 18(1): 29. https://doi.org/10.1186/s12885-017-3877-1
Pereira IC, Mascarenhas IF, Capetini VC, Ferreira PMP, Rogero MM, Torres-Leal FL. Cellular reprogramming, chemoresistance, and
dietary interventions in breast cancer. Crit Rev Oncol Hematol. 2022; 179: 103796. https://doi.org/10.1016/j.critrevonc.2022.103796
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017; 67(5): 378–397. https://doi.org/10.3322/caac.21405
Queiroga FL, Pérez-Alenza MD, Silvan G, Peña L, Lopes C, Illera JC. Role of steroid hormones and prolactin in canine mammary cancer. J
Steroid Biochem Mol Biol. 2005; 94(1-3): 181–187. https://doi.org/10.1016/j.jsbmb.2004.12.014
Ren X, Fan Y, Shi D, Liu Y. Expression and significance of IL-6 and IL-8 in canine mammary gland tumors. Sci Rep. 2023; 13: 1302. https://doi.org/10.1038/s41598-023-28389-3
Rosendahl AH, Bergqvist M, Lettiero B, Kimbung S, Borgquist S. Adipocytes and ObesityRelated Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis. Front Endocrinol. 2018; 9: 689. https://doi.org/10.3389/fendo.2018.00689
Sahabi K, Selvarajah GT, Abdullah R, Cheah YK, Tan GC. Comparative aspects of microRNA expression in canine and human cancers. J Vet Sci. 2018; 19(2): 162–171. https://doi.org/10.4142/jvs.2018.19.2.162
Sankofi BM, Valencia-Rincón E, Sekhri M, Ponton-Almodovar AL, Bernard JJ, Wellberg EA. The impact of poor metabolic health
on aggressive breast cancer: adipose tissue and tumor metabolism. Front Endocrinol. 2023; 14: 1217875. https://doi.org/10.3389/ fendo.2023.1217875
Seung BJ, Lim HY, Shin JI, Kim HW, Cho SH, Kim SH, Sur JH. CD204-Expressing TumorAssociated Macrophages Are Associated With Malignant, High-Grade, and Hormone ReceptorNegative Canine Mammary Gland Tumors. Vet Pathol. 2018; 55(3): 417–424. https://doi.org/10.1177/0300985817750457
Shin JI, Lim HY, Kim HW, Seung BJ, Ju JH, Sur JH. Analysis of obesity-related factors and their association with aromatase expression in canine malignant mammary tumours. J Comp Pathol. 2016; 155(1): 15-23. https://doi.org/10.1016/j.jcpa.2016.05.005
Tamarindo GH, Novais AA, Chuffa LGA, Zuccari DAPC. Metabolic Alterations in Canine Mammary Tumors. Animals 2023; 13(17): 2757.
https://doi.org/10.3390/ani13172757
Taroeno-Hariadi KW, Hardianti MS, Sinorita H, Aryandono T. Obesity, leptin, and deregulation of microRNA in lipid metabolisms: their contribution to breast cancer prognosis. Diabetol Metab Syndr. 2021; 13(1): 10. https://doi.org/10.1186/s13098-020-00621-4
Tong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive
Breast Cancer Patients. Front Oncol. 2020; 10: 550. https://doi.org/10.3389/fonc.2020.00550
Wu C, Dong S, Huang R, Chen X. Cancer Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment
and Challenges for Cancer Therapy. Cancers 2023; 15(3): 726. https://doi.org/10.3390/cancers15030726
Zhong W, Wang X, Wang Y, Sun G, Zhang J, Li Z. Obesity and endocrine-related cancer: The important role of IGF-1. Front Endocrinol.
; 14: 1093257. https://doi.org/10.3389/fendo.2023.1093257
Zhu Y, Wang T, Tong Y, Chen X, Shen K. 21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients. Front Endocrinol. 2021; 12: 725161. https://doi.org/10.3389/fendo.2021.725161
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Revista Colombiana de Ciencias Pecuarias
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors enable RCCP to reprint the material published in it.
The journal allows the author(s) to hold the copyright without restrictions, and will allow the author(s) to retain publishing rights without restrictions.
